FAM
GMAB icon

Fred Alger Management’s Genmab GMAB Stock Holding History

Fred Alger Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-130,470
Closed -$4.02M – 480
2025
Q4 		$4.02M Buy
+130,470
New +$4.07M 0.02% 264
2021
Q2 		– Sell
-78,338
Closed -$2.57M – 525
2021
Q1 		$2.57M Sell
78,338
-582,249
-88% -$21.9M 0.01% 333
2020
Q4 		$26.9M Buy
660,587
+167,677
+34% +$6.27M 0.07% 180
2020
Q3 		$18M Sell
492,910
-27,380
-5% -$990K 0.05% 176
2020
Q2 		$17.6M Buy
520,290
+295,191
+131% +$8.04M 0.06% 166
2020
Q1 		$4.77M Sell
225,099
-192,913
-46% -$4.3M 0.02% 213
2019
Q4 		$9.33M Buy
418,012
+186,879
+81% +$4.08M 0.03% 201
2019
Q3 		$4.68M Buy
+231,133
New +$4.55M 0.02% 225

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Fred Alger Management's GMAB Position: Q1 2026 in Review

Fred Alger Management sold out of Genmab (GMAB) in Q1 2026, closing a stake of 130,470 shares — an estimated $4.02M sold.

Fred Alger Management first reported a position in GMAB in Q3 2019 and held it in 8 quarters. The position peaked at $26.9M in Q4 2020. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Fred Alger Management reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Fred Alger Management sold 130,470 Genmab shares in Q1 2026, an estimated $4.02M.
  • Fred Alger Management first reported a position in Genmab in Q3 2019 and held it in 8 quarters.
  • Fred Alger Management's Genmab position peaked at $26.9M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.